Company Filing History:
Years Active: 2008
Title: Anne Braunstein: Innovator in Pharmaceutical Formulations
Introduction
Anne Braunstein is a notable inventor based in Modiin, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the formulation of stable medications. Her work has the potential to enhance the efficacy and stability of important therapeutic agents.
Latest Patents
Anne holds a patent for a "Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof." This patent describes formulations of a stable commercial paroxetine tablet that includes paroxetine hydrochloride anhydrous, povidone, copovidone, or HPMC as a binder, along with an HCl free/non-hygroscopic filler, prepared by the wet granulation method. This innovation is crucial for improving the stability and usability of paroxetine tablets.
Career Highlights
Anne Braunstein is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her work at Teva has allowed her to focus on developing advanced pharmaceutical formulations that meet the needs of patients and healthcare providers.
Collaborations
Anne has collaborated with notable colleagues, including Michael Fox and Rakefet Cohen. These partnerships have contributed to her success in the pharmaceutical industry and have fostered an environment of innovation and creativity.
Conclusion
Anne Braunstein's contributions to pharmaceutical formulations exemplify the importance of innovation in healthcare. Her patent for a stable paroxetine tablet formulation showcases her commitment to improving medication stability and efficacy.